AE

Andrew ElBardissi

Partner at Deerfield Management

New York, New York

Investor
VC

Invests in

Stages:

Seed
Series A

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Healthcare
Healthcare Information Technology
Data Analysis
Strategic Planning
Analysis
Management Consulting
Strategy
Entrepreneurship
Business Strategy
Financial Modeling
Corporate Finance
Market Research
Competitive Analysis
Due Diligence
Financial Analysis
Venture Capital
Investments
Medical Devices
Investment Banking
Clinical Research

Education

Lists including Andrew

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

MMI

Series B

Total Funding: $210M

Bitterroot Bio

Series A

Total Funding: $150M

Epic Sciences

Series G

Total Funding: $160M

Pleno

Series A

Total Funding: $40M

Aurion Biotechnologies

Series Unknown

Total Funding: $120M

V-Wave

Series C

Total Funding: $200M

GeneDx

Series C

Total Funding: $240M

Element Science

Series C

Total Funding: $150M

Sollis Therapeutics

Series Unknown

Total Funding: $50M

Work Experience

DM
Deerfield Management

2017

  • Partner

    2017

MM
Medical Microinstruments, Inc.

2022

  • Board Member

    2022

AB
Aurion Biotech

2022

  • Board Member

    2022

Bitteroot

2021

  • Board Member

    2021

Adela Bio

2021

  • Board Member

    2021

EI
Encodia, Inc.

2020

  • Board Member

    2020

EL
Endologix LLC

2020

  • Board Member

    2020

S
Sema4

2020

  • Board Member

    2020

RC
Reprieve Cardiovascular

2020

  • Board Member

    2020

ES
Element Science, Inc.

2019

  • Board Member

    2019